Results 281 to 290 of about 176,389 (357)

NAFLD-associated immune remodeling in colorectal cancer liver metastasis: mechanisms and implications for immunotherapy. [PDF]

Front Immunol
Wang H, Gu G.
europepmc   +1 more source

Identification of Changes in Gene Expression

Biometrical Journal, Volume 68, Issue 5, October 2026.
ABSTRACT Evaluating the change in gene expression is a common goal in many research areas, such as in toxicological studies, which are particularly important in pre‐clinical research. In practice, the analysis is often based on multiple t‐tests evaluated at the observed time points of the experiment, which limits the accuracy of determining the precise
Lucia Ameis, Kathrin Möllenhoff
wiley   +1 more source

The NLRP3 inflammasome in metabolic dysfunction-associated steatotic liver disease: role and advances in therapeutic targeting. [PDF]

Front Immunol
Wei S, He Y, Luo C, He X.
europepmc   +1 more source

Understanding the Potential of Antibody‐Drug Conjugates Functionalized Engineered Exosomes in Hepatocellular Carcinoma Therapy: A Comprehensive Narrative Review

Health Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Exosomes are naturally secreted nanovesicles with high biocompatibility, low immunogenicity, and the ability to traverse biological barriers, making them attractive theragnostic carriers. When engineered to present tumor‐specific antibodies and to deliver antibody‐drug conjugates (ADCs), they may enhance selective targeting of ...
Subham Sarkar, Avinaba Bose, Jenifer Rajak, Arup Kumar Mitra, Ajoy Kumer, Bikram Dhara   +5 more
wiley   +1 more source

Cytokeratin-18 increase as a signal for early liver cell changes in high-fat diet-induced obesity before overt steatohepatitis. [PDF]

Front Endocrinol (Lausanne)
Özdemir Ö, Akalın Ç, Ekiz F, Öğüten PN, Baş O, Bayrak A, Kaşko Arıcı Y.   +6 more
europepmc   +1 more source

Impact of nonalcoholic fatty liver disease on the response to pegylated interferon-α therapy in patients with chronic hepatitis B. [PDF]

Microbiol Spectr
Liang H, Xie Y, Dai Y, Yang X, Zheng X, Yang J, Liu Y, Wu C, Chen S, Zhang M, Zhuang H, Lin L, Chen S.   +12 more
europepmc   +1 more source

Hepatic lipid accumulation induced by mono-(2-ethylhexyl) phthalate and potential ERBB2-associated inflammatory signaling in NAFLD. [PDF]

Front Pharmacol
Huang C, Yin M, Liu H, Jia W, Niu L, Ming J.   +5 more
europepmc   +1 more source

Socioeconomic Factors and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review. [PDF]

Liver Int
Wiering L, Demir M.
europepmc   +1 more source

Comparative performance of insulin resistance-related indices in predicting adverse cardiovascular events among individuals with NAFLD and MASLD: a multi-center cohort study. [PDF]

Cardiovasc Diabetol
Huang Y, Xu Y, Zhang C, Gu W, Li Y, Zhang H, Wang T, Su T, Lhamu Y, Chen Y, Zhou L, Hao L, Yang Y, Wang H.   +13 more
europepmc   +1 more source

Erratum: Association of Fasting C-Peptide to High Density Lipoprotein Cholesterol Ratio with Non-Alcoholic Fatty Liver Disease in Chinese Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study [Corrigendum]. [PDF]

Diabetes Metab Syndr Obes
europepmc   +1 more source